| Heading: |
Drugs: Licensing |
| Question ID: |
1758419 |
| UIN: |
26255 |
| House: |
Commons |
| Date tabled: |
2025-01-23 |
| Asking Member ID: |
5297 |
| Asking Member display name: |
Rebecca Paul
|
| Asking Member handle: |
Rebecca_SPaul
|
| Asking Member Twitter reference: |
@Rebecca_SPaul
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 October 2024 to Question 7682 on Cancer: Medical Treatments, when he plans to publish the updated NHS Commercial Framework for New Medicines. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-01-31 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
NHS England published its updated Commercial Framework for New Medicines on 29 January 2025. The publication can be found here: NHS England ยป NHS commercial framework for new medicines |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |